Effect of Transfusion of Plasma on Endothelial During Liver Transplantation
NCT ID: NCT04107883
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-10-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
perform artificial colloidal solution transfusion during anhapetic phase.
blood sample
get blood samples at several specific points in time during perioperation
anhapetic group
Perform plasma transfusion during anhapetic phase.
fresh frozen plasma
perform plasma transfusion in different phases during perioperation
blood sample
get blood samples at several specific points in time during perioperation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fresh frozen plasma
perform plasma transfusion in different phases during perioperation
blood sample
get blood samples at several specific points in time during perioperation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who undergo the first OLT
* Informed and consented
* complete follow-up
* cooperate with treatment
Exclusion Criteria
* combined liver and other organ transplantation
* BMI≥30Kg/m2
* patients with hypertension, diabetes, coronary heart disease, chronic renal insufficiency, preoperative pulmonary infection, pleural effusion
* acute liver failure
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Chao Yang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xun Liu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anshi Wu
Role: STUDY_CHAIR
Capital Medical University Affiliated Beijing Chaoyang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Capital Medical University Affiliated Beijing Chaoyang Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LX-2019-LT-1
Identifier Type: -
Identifier Source: org_study_id